Compare Globus Medical Inc. Class A Common Stock (GMED) vs Western Union Co (WU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs Western Union Co — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.58 (market cap $10.25B), while Western Union Co trades at $6.05 (market cap $1.90B). The key difference: Globus Medical Inc. Class A Common Stock is far larger — about 5.4× Western Union Co's market cap, and Western Union Co pays a 15.41% dividend while Globus Medical Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and Western Union Co for 96 Days on average.
| GMED | WU | |
|---|---|---|
Market Cap | $10.25B | $1.90B |
Volume | 1,108,124 | 6,506,793 |
Sector | Health | Financials |
52-Week High | $96.82 | $10.28 |
52-Week Low | $58.33 | $5.90 |
Typical Hold Time | 0 Days | 96 Days |
Enterprise Value | $9.76B | $1.81B |
Dividend Yield | — | 15.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
Western Union (WU) trades at $6.10, down 0.16% with a bearish technical outlook. The stock shows attractive valuation metrics including a P/E of 4.92 and P/S of 0.48, while maintaining strong profitability with 35.09% gross margins and 43.97% ROE. Recent earnings show mixed performance with two misses in the last three quarters. The company is implementing a $200 million cost-cutting plan and expanding retail partnerships while navigating regulatory approval for its Intermex acquisition.
WU presents a value opportunity with deep discount valuation but faces execution risks. The turnaround strategy and digital transformation offer potential upside if successful, though recent earnings volatility and competitive pressures warrant caution. Analyst consensus is mixed with a $6.71 price target representing 10% upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →
